ArTS Archivio della ricerca di Trieste

DECORTI, GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.673
EU - Europa 11.850
AS - Asia 9.989
SA - Sud America 1.232
Continente sconosciuto - Info sul continente non disponibili 960
AF - Africa 358
OC - Oceania 42
Totale 47.104
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.318
SG - Singapore 3.679
PL - Polonia 2.741
IT - Italia 2.533
CN - Cina 2.181
SE - Svezia 1.310
VN - Vietnam 1.112
UA - Ucraina 979
BR - Brasile 929
HK - Hong Kong 921
DE - Germania 830
FI - Finlandia 634
FR - Francia 574
GB - Regno Unito 534
BD - Bangladesh 452
KR - Corea 444
RU - Federazione Russa 414
TR - Turchia 307
NL - Olanda 306
IE - Irlanda 250
IN - India 234
BG - Bulgaria 223
CA - Canada 160
JP - Giappone 124
MA - Marocco 106
AR - Argentina 104
MX - Messico 96
BE - Belgio 85
ES - Italia 73
IQ - Iraq 73
PK - Pakistan 65
ZA - Sudafrica 58
AT - Austria 57
SN - Senegal 54
ID - Indonesia 52
CH - Svizzera 51
CZ - Repubblica Ceca 48
EC - Ecuador 40
SA - Arabia Saudita 40
CO - Colombia 38
CL - Cile 36
PH - Filippine 36
TH - Thailandia 36
AU - Australia 35
EG - Egitto 32
TN - Tunisia 31
VE - Venezuela 29
UZ - Uzbekistan 28
AE - Emirati Arabi Uniti 26
PT - Portogallo 24
PE - Perù 23
GR - Grecia 20
JO - Giordania 20
RO - Romania 19
IL - Israele 18
MY - Malesia 18
AZ - Azerbaigian 17
JM - Giamaica 17
KE - Kenya 17
PY - Paraguay 17
SI - Slovenia 17
RS - Serbia 16
TW - Taiwan 16
CR - Costa Rica 14
DZ - Algeria 14
DK - Danimarca 13
GT - Guatemala 12
IR - Iran 12
LT - Lituania 11
MD - Moldavia 10
NO - Norvegia 10
AL - Albania 9
HU - Ungheria 9
NP - Nepal 9
EU - Europa 8
KW - Kuwait 8
NG - Nigeria 8
PA - Panama 8
UY - Uruguay 8
BA - Bosnia-Erzegovina 7
BO - Bolivia 7
ET - Etiopia 7
HN - Honduras 7
HR - Croazia 7
LB - Libano 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
EE - Estonia 6
KZ - Kazakistan 6
LK - Sri Lanka 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
SV - El Salvador 6
BY - Bielorussia 5
GA - Gabon 5
KG - Kirghizistan 5
LU - Lussemburgo 5
NI - Nicaragua 5
CI - Costa d'Avorio 4
Totale 46.066
Salva come PNG Salva come JPEG
Città #
Warsaw 2.477
Ashburn 2.392
Singapore 2.222
Woodbridge 2.166
Ann Arbor 1.851
Fairfield 1.848
Houston 1.367
Chandler 1.315
San Jose 1.156
Hong Kong 891
Wilmington 886
Jacksonville 860
Seattle 824
Trieste 699
Cambridge 592
Council Bluffs 509
Beijing 496
Seoul 419
Princeton 396
Hefei 376
Boardman 372
Munich 338
Ho Chi Minh City 327
Los Angeles 307
Columbus 287
Chicago 281
Hanoi 278
Helsinki 270
Milan 249
Dublin 229
Izmir 227
Sofia 221
Lauterbourg 219
Dallas 209
Zgierz 200
Santa Clara 197
Moscow 194
London 174
New York 173
The Dalles 157
Buffalo 150
Frankfurt am Main 145
Dearborn 131
São Paulo 107
Rome 106
San Diego 102
Düsseldorf 91
Casablanca 87
Phoenix 80
Brussels 78
Tokyo 75
Shanghai 66
Orem 63
Atlanta 58
Dakar 54
Des Moines 51
Memphis 51
Redondo Beach 48
Da Nang 47
Montreal 45
Turku 45
Brooklyn 44
Falls Church 43
Denver 42
Guangzhou 42
Toronto 42
Amsterdam 41
Haiphong 41
Chennai 40
Manchester 40
Brno 38
Washington 38
Nuremberg 37
Vienna 37
Dong Ket 36
Johannesburg 36
Mumbai 36
Nanjing 36
Wroclaw 36
Stockholm 35
Bern 34
Tianjin 34
Verona 34
Bremen 33
Miano 33
Redwood City 32
Curitiba 31
Jinan 31
Lappeenranta 30
Baghdad 28
Bologna 27
Tashkent 27
Charlotte 25
Fremont 25
Rio de Janeiro 25
San Francisco 25
Boston 24
Kunming 24
Norwalk 24
Shenyang 24
Totale 31.641
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 548
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis 543
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 517
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 496
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 491
Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines' Toxic Effects 465
Pharmacogenetics of thiopurines 453
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 437
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms 435
Genetic determinants for methotrexate response in juvenile idiopathic arthritis 422
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 422
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? 411
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 404
Pharmacogenetics of treatments for inflammatory bowel disease 383
In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome 353
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 342
Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide 321
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 317
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 313
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 302
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 300
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 300
Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes 296
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 294
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment 293
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 293
Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. 292
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease 290
Effect of thalidomide on clinical remission in children and adolescents with ulcerative colitis refractory to other immunosuppressives: Pilot randomized clinical trial 281
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. 278
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. 278
Ergothioneine, a dietary amino acid with a high relevance for the interpretation of label-free surface enhanced Raman scattering (SERS) spectra of many biological samples 278
Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability 274
Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. 274
Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells. 272
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 272
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 272
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 271
Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient 270
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 269
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 267
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 266
Amelioration of 4'-Epidoxorubicin-induced cardiotoxicity by sodium cromoglycate. 262
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 261
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 260
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 259
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 259
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 259
Hemolytic Effects of Water-Soluble Fullerene Derivatives 257
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient 255
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT∗3 alleles 251
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 250
Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. 249
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 247
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse. 244
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. 243
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 243
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol 242
Effect of periodontal therapy on the course of cyclosporin-induced gingival overgrowth: role of ABCB1 and PAI-1 gene polymorphisms. 241
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 240
Glutathione-S-Transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome 238
Anticonvulsant activity of two polyethylene glycols in mice. 238
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 236
The cytotoxic effect of palytoxin on Caco-2 cells hinders their use for in vitro absorption studies. 235
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 235
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches. 234
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. 234
Adriamycin binds to the matrix of secretory granules during mast cell exocytosis. 232
Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells. 231
ABCB1 gene polymorphisms and expression of P-glycoprotein and long term prognosis in colorectal cancer 231
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 231
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 231
Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. 230
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease 227
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 227
SERS of cells: What can we learn from cell lysates? 227
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 226
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 224
Biochemical and microscopic evidence for the internalization of drug-containing mast cell granules by macrophages and smooth muscle cells 224
Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. 222
Effect of neomycin and other aminoglycosides on adriamycin uptake in rat peritoneal mast cells. 221
Effect of ketotifen on adriamycin toxicity: role of histamine. 220
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. 217
Glucocorticoids in Pediatric Gastrointestinal Disorders 216
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 213
Selective resistance to different glucocorticoids in severe autoimmune disorders 213
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 212
Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases 210
Adriamycin-induced histamine release from heart tissue in vitro. 210
Cellular antioxidant activities and cytotoxic properties of ethanolic extracts of four tropical green leafy vegetables 210
Osteonecrosis of the hip after short courses of oral and inhaled steroids in a child with an increased number of glucocorticoid receptors 210
Visualization of adriamycin uptake and internalization by receptor-mediated endocytosis in mast cells. An ultrastructural study using adriamycin-colloidal gold complexes. 209
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype 209
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance 209
Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. 207
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 207
Personalized therapies in pediatric inflammatory and autoimmune diseases. 205
Glutathione S-Transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. 205
Adriamycin experimental cardiomyopathy in Swiss mice. Different effects of two calcium antagonistic drugs on ADM - induced cardiomyopathy. 204
Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart 203
Totale 27.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.313 0 0 123 243 56 225 186 104 299 277 160 640
2022/20233.860 372 559 271 571 369 647 32 318 425 57 162 77
2023/20242.382 128 170 107 139 249 197 444 460 39 66 225 158
2024/20256.105 120 245 401 573 571 644 415 418 780 767 575 596
2025/202613.636 1.306 633 825 1.065 1.230 1.265 2.022 430 1.553 1.862 856 589
2026/20271.585 485 733 367 0 0 0 0 0 0 0 0 0
Totale 47.104